Semaglutide
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
Novo Nordisk · Phase 3 · Status n/r · Enrollment 480
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity + T2D | n/r | 5 | n/r | n/r |